|
OptiBiotix Health PLC - York, England-based life sciences firm - Shares begin trading on the OTCQB Venture Market in the US at Thursday’s market open under the symbol OPTBF. Notes this will not impact shares trading on the AIM Market in London. ‘OptiBiotix is building its consumer presence in the USA as shown by the recent launch of its appetite reducing SlimBiome in Hydroxycut, the [number] 1 selling weight loss supplement brand in the USA,’ says Chief Executive Officer Stephen O’Hara. ‘This follows on from launches earlier this year with new US partners such as NHT and Daily Nouri. As we increase our brand presence in the USA the board believe joining the OTCQB Market will help increase our visibility to the US investment community, broadening our shareholder base and improving liquidity.’ Current stock price: 12.16 pence, down 1.7% in London on Thursday afternoon 12-month change: down 49% Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
